+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890303
The global kidney cancer therapeutics & diagnostics market size was estimated to be USD 5.07 billion in 2023 and is expected to reach at USD 11.09 billion by 2034 with a CAGR of 7.38% during the forecast period 2024-2034. Growing prevalence of kidney cancer, rising research & development expenditures by market players, surge in product launches by the key market players, increasing funding for kidney cancer research, growing cases of renal cell carcinoma, rising demand for early diagnosis of kidney cancer, and increasing focus on development of novel therapy for kidney cancer are some of the key factors boosting the market growth.

Increasing focus on development of novel therapy for kidney cancer is predicted to boost the market growth during the forecast period. The diagnosis and treatment of kidney cancer include the use of therapies and diagnostics for renal cell carcinoma (RCC), Wilms tumors, transitional cell cancer, renal sarcoma, multilocular cystic RCC, medullary carcinoma, benign kidney tumors, and mucinous tubular and spindle cell carcinoma. Thus, there is a growing need for innovative therapies as kidney cancer incidence rises. For instance, in October 2022, Health Canada has granted approval for KEYTRUDA (pembrolizumab) to be used on its own in the adjuvant treatment of adults who have undergone nephrectomy or both nephrectomy and removal of metastatic growths, and who have intermediate-high or high risk of renal cell carcinoma (RCC) recurrence.

By cancer type, clear cell renal cell carcinoma was the highest revenue-grossing segment in the global kidney cancer therapeutics & diagnostics market in 2023 owing to rising prevalence of renal disorders, increasing adoption of various techniques in the diagnosis of ccRCC cancer, surge in research & development activity, and growing approvals by regulatory bodies. For instance, in November 2022, Aravive, Inc.'s primary initiative, batiraxcept, has been awarded Fast Track Designation by the U.S. FDA for patients dealing with advanced or metastatic clear cell renal cell carcinoma (ccRCC). This designation applies to cases where patients have experienced progression after receiving one or two earlier rounds of systemic treatment, encompassing both immune-oncology (IO) and vascular endothelial growth factor (VEGF) therapies. Additionally, urothelial carcinoma/transitional cell carcinoma is predicted to grow at fastest CAGR during the forecast period owing to the increasing cases of urothelial carcinoma, growing demand for chemotherapy, surge in research for the development of new drugs, and rising drug approvals by regulatory bodies.

By component, drugs was the highest revenue-grossing segment in the global kidney cancer therapeutics & diagnostics market in 2023 owing to growing prevalence of renal disorders, increasing need for novel treatments for the treatment of cancer and rising approvals by regulatory bodies. For instance, in August 2022, Celltrion Healthcare's Vegzelma (CT-P16) has received approval from the European Commission (EC) for treating metastatic renal cell carcinoma and other types of malignancies. Additionally, diagnostics is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of kidney disorders, growing research & development activities, and increasing demand for early disease diagnosis.

By end-user, hospitals was the highest revenue-grossing segment in the global kidney cancer therapeutics & diagnostics market in 2023 owing to surge in number of people suffering from kidney disorders, rising healthcare infrastructure, and surge in introduction of innovative drugs. Additionally, pharmaceutical labs is predicted to grow at fastest CAGR during the forecast period owing to the increasing focus on development of advanced diagnostic techniques, growing research & development activities, and rising funding by major market players. For instance, in September 2022, The Department of Defense's Kidney Cancer Research Program has granted Weill Cornell Medicine $1 million over three years for research investigating the function of the protein ATF4 in clear cell renal cell carcinoma (ccRCC), a type of kidney cancer.

North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of kidney cancer, rising product launches by the key market players, growing research & development expenditures by pharmaceutical companies, and increasing funding for research. For instance, in April 2023, The FY23 Defense Appropriations Act allocates funds for the Kidney Cancer Research Program (KCRP), specifically to back high-quality scientific research focused on kidney cancer. The entity responsible for overseeing the forthcoming funding opportunities is the CDMRP, housed within the U.S. Army Medical Research and Development Command (USAMRDC). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising incidences of kidney cancer, growing geriatric population, increasing awareness regarding cancer, surge in research & development expenditure by pharmaceutical companies, rising launch of novel drugs for the treatment of kidney cancer, and growing initiatives by major market players. For instance, in March 2023, Telix has reported further favorable findings from its concluded pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in patients with clear cell renal cell carcinoma (ccRCC).

Segmentation: Kidney Cancer Therapeutics & Diagnostics Market Report 2022 - 2033

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast by Cancer Type 2023 - 2034 (Revenue USD Bn)

  • Papillary Renal Cell Carcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Urothelial Carcinoma/Transitional Cell Carcinoma
  • Others
  • Renal Sarcoma
  • Collecting Duct Renal Cell Carcinoma
  • Wilms Tumor

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast by Component 2023 - 2034 (Revenue USD Bn)

Drugs

  • Therapeutic Class
  • Targeted Therapy
  • Immunotherapy
  • Others
  • Pharmacologic Class
  • Angiogenesis Inhibitors
  • Monoclonal Antibodies
  • mTOR Inhibitors
  • Cytokine Immunotherapy (IL-2)

Diagnostics

  • Biopsy
  • Imaging Tests
  • Blood Tests
  • Others

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Genomic Laboratories
  • Pharmaceutical Labs
  • Hospitals
  • Others

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Kidney Cancer Therapeutics & Diagnostics Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Kidney Cancer Therapeutics & Diagnostics Market: Cancer Type Estimates & Trend Analysis
7.1. Cancer Type Segment Opportunity Analysis
7.2. Papillary Renal Cell Carcinoma
7.2.1. Papillary Renal Cell Carcinoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Chromophobe Renal Cell Carcinoma
7.3.1. Chromophobe Renal Cell Carcinoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Clear Cell Renal Cell Carcinoma
7.4.1. Clear Cell Renal Cell Carcinoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Urothelial Carcinoma/Transitional Cell Carcinoma
7.5.1. Urothelial Carcinoma/Transitional Cell Carcinoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Others
7.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6.2. Renal Sarcoma
7.6.2.1. Renal Sarcoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6.3. Collecting Duct Renal Cell Carcinoma
7.6.3.1. Collecting Duct Renal Cell Carcinoma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6.4. Wilms Tumor
7.6.4.1. Wilms Tumor Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Kidney Cancer Therapeutics & Diagnostics Market: Component Estimates & Trend Analysis
8.1. Component Segment Opportunity Analysis
8.2. Drugs
8.2.1. Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.2. Therapeutic Class
8.2.2.1. Therapeutic Class Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.2.2. Targeted Therapy
8.2.2.2.1. Targeted Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.2.3. Immunotherapy
8.2.2.3.1. Immunotherapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.2.4. Others
8.2.2.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.3. Pharmacologic Class
8.2.3.1. Pharmacologic Class Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.3.2. Angiogenesis Inhibitors
8.2.3.2.1. Angiogenesis Inhibitors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.3.3. Monoclonal Antibodies
8.2.3.3.1. Monoclonal Antibodies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.3.4. mTOR Inhibitors
8.2.3.4.1. mTOR Inhibitors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.2.3.5. Cytokine Immunotherapy (IL-2)
8.2.3.5.1. Cytokine Immunotherapy (IL-2) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Diagnostics
8.3.1. Diagnostics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3.2. Biopsy
8.3.2.1. Biopsy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3.3. Imaging Tests
8.3.3.1. Imaging Tests Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3.4. Blood Tests
8.3.4.1. Blood Tests Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3.5. Others
8.3.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Kidney Cancer Therapeutics & Diagnostics Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Genomic Laboratories
9.2.1. Genomic Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Pharmaceutical Labs
9.3.1. Pharmaceutical Labs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Hospitals
9.4.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Others
9.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Kidney Cancer Therapeutics & Diagnostics Market
11.1. North America Kidney Cancer Therapeutics & Diagnostics Market
11.1.1. North America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
11.1.4. North America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
11.1.5. North America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Kidney Cancer Therapeutics & Diagnostics Market
11.2.1. U.S. Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Kidney Cancer Therapeutics & Diagnostics Market
11.3.1. Canada Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Kidney Cancer Therapeutics & Diagnostics Market
12.1. Europe Global Kidney Cancer Therapeutics & Diagnostics Market
12.1.1. Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Kidney Cancer Therapeutics & Diagnostics Market
12.2.1. Germany Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Kidney Cancer Therapeutics & Diagnostics Market
12.3.1. UK Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.3.3. UK Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.3.4. UK Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Kidney Cancer Therapeutics & Diagnostics Market
12.4.1. France Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.4.3. France Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.4.4. France Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Kidney Cancer Therapeutics & Diagnostics Market
12.5.1. Spain Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Kidney Cancer Therapeutics & Diagnostics Market
12.6.1. Italy Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Kidney Cancer Therapeutics & Diagnostics Market
12.7.1. Rest of Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Kidney Cancer Therapeutics & Diagnostics Market
13.1. Asia Pacific Global Kidney Cancer Therapeutics & Diagnostics Market
13.1.1. Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Kidney Cancer Therapeutics & Diagnostics Market
13.2.1. Japan Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Kidney Cancer Therapeutics & Diagnostics Market
13.3.1. China Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.3.3. China Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.3.4. China Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Kidney Cancer Therapeutics & Diagnostics Market
13.4.1. India Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.4.3. India Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.4.4. India Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Kidney Cancer Therapeutics & Diagnostics Market
13.5.1. South Korea Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Kidney Cancer Therapeutics & Diagnostics Market
13.6.1. Australia Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Kidney Cancer Therapeutics & Diagnostics Market
13.7.1. Rest of Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Kidney Cancer Therapeutics & Diagnostics Market
14.1. Latin America Global Kidney Cancer Therapeutics & Diagnostics Market
14.1.1. Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Kidney Cancer Therapeutics & Diagnostics Market
14.2.1. Brazil Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Kidney Cancer Therapeutics & Diagnostics Market
14.3.1. Mexico Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Kidney Cancer Therapeutics & Diagnostics Market
14.4.1. Argentina Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Kidney Cancer Therapeutics & Diagnostics Market
14.5.1. Rest of Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Kidney Cancer Therapeutics & Diagnostics Market
15.1. MEA Global Kidney Cancer Therapeutics & Diagnostics Market
15.1.1. MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Kidney Cancer Therapeutics & Diagnostics Market
15.2.1. GCC Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Kidney Cancer Therapeutics & Diagnostics Market
15.3.1. South Africa Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Kidney Cancer Therapeutics & Diagnostics Market
15.4.1. Rest of MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Cancer Type, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By Component, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Kidney Cancer Therapeutics & Diagnostics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Novartis AG
17.2. Amgen Inc.
17.3. Pfizer Inc.
17.4. Abbott Laboratories
17.5. Bristol-Myers Squibb Company
17.6. F. Hoffmann-La Roche
17.7. Exelixis Inc.
17.8. Bayer AG
17.9. Seattle Genetic
17.10. Merck KGaA (EMD Serono)
17.11. Genentech Inc.
17.12. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Novartis AG
  • Amgen Inc.
  • Pfizer Inc.
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche
  • Exelixis Inc.
  • Bayer AG
  • Seattle Genetic
  • Merck KGaA (EMD Serono)
  • Genentech Inc.

Table Information